HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mickle, D. A. Articles by Ingold, K. U. Search for Related Content PubMed PubMed Citation Articles by Mickle, D. A. Articles by Ingold, K. U.

The Annals of Thoracic Surgery, Vol 47, 553-557, Copyright © 1989 by The Society of Thoracic Surgeons

ARTICLES

Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction

DA Mickle, RK Li, RD Weisel, PL Birnbaum, TW Wu, G Jackowski, MM Madonik, GW Burton and KU Ingold
Department of Clinical Biochemistry, Toronto General Hospital, University of Toronto, Ontario, Canada.

Both Trolox (a water-soluble analogue of alpha-tocopherol) and ascorbic acid were more effective than superoxide dismutase or catalase in protecting myocyte cell cultures from free radical attack (induced by hypoxanthine and xanthine oxidase). In a canine model of two hours of left anterior descending coronary artery occlusion followed by four hours of reperfusion, Trolox and ascorbic acid reduced the area of infarction within the area at risk. The Trolox group received 500 mL of deoxygenated saline solution containing 2.0 g of Trolox, 3.0 g of ascorbic acid, and 18 mg of EDTA (ethylenediaminetetraacetic acid) infused into the ascending aorta 30 seconds before and four minutes after reperfusion. Saline controls received 500 mL of deoxygenated saline solution containing 18 mg of EDTA. The angioplasty group had unmodified reperfusion by simple release of the occlusion. The area at risk and the area infarcted were estimated with Evans blue and triphenyl tetrazolium hydrochloride stains, respectively. The ratio of the area infarcted to the area at risk was significantly lower with Trolox (angioplasty, 30.4% +/- 5.1%; saline, 20.8% +/- 2.9%; and Trolox, 8.7% +/- 4.0%; p less than 0.01). In summary, the antioxidants Trolox and ascorbic acid effectively reduced myocardial necrosis after ischemia.

This article has been cited by other articles:

				E. T. Donnelly, N. McClure, and S. E.M. Lewis The effect of ascorbate and {alpha}-tocopherol supplementation in vitro on DNA integrity and hydrogen peroxide-induced DNA damage in human spermatozoa Mutagenesis, September 1, 1999; 14(5): 505 - 512. [Abstract] [Full Text] [PDF]

				J. Westhuyzen, A. D. Cochrane, P. J. Tesar, T. Mau, D. B. Cross, M. P. Frenneaux, F. A. Khafagi, and S. J. Fleming EFFECT OF PREOPERATIVE SUPPLEMENTATION WITH {{alpha}}-TOCOPHEROL AND ASCORBIC ACID ON MYOCARDIAL INJURY IN PATIENTS UNDERGOING CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 942 - 948. [Abstract] [Full Text]

				J. S. Ikonomidis, V. Rao, R. D. Weisel, N. Hayashida, and T. Shirai Myocardial Protection for Coronary Bypass Grafting: The Toronto Hospital Perspective Ann. Thorac. Surg., September 1, 1995; 60(3): 824 - 832. [Abstract] [Full Text]

				T. M. Yau, R. D. Weisel, D. A. G. Mickle, G. W. Burton, K. U. Ingold, J. Ivanov, M. K. Mohabeer, L. Tumiati, and S. Carson Vitamin E for coronary bypass operationsA prospective, double-blind, randomized trial J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 302 - 310. [Abstract] [Full Text]